Cargando…
Progesterone in traumatic brain injury: time to move on to phase III trials
There are several candidate neuroprotective agents that have been shown in preclinical testing to improve outcomes following traumatic brain injury (TBI). Xiao and colleagues have performed an in hospital, double blind, randomized, controlled clinical trial utilizing progesterone in the treatment of...
Autores principales: | Vandromme, Marianne, Melton, Sherry M, Kerby, Jeffrey D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481452/ https://www.ncbi.nlm.nih.gov/pubmed/18522765 http://dx.doi.org/10.1186/cc6899 |
Ejemplares similares
-
Suboptimal Dosing Parameters as Possible Factors in the Negative Phase III Clinical Trials of Progesterone for Traumatic Brain Injury
por: Howard, Randy B., et al.
Publicado: (2017) -
Urinalysis and pre-renal acute kidney injury: time to move on
por: Schneider, Antoine G, et al.
Publicado: (2013) -
Neuroprotection by Estrogen and Progesterone in Traumatic Brain Injury and Spinal Cord Injury
por: Brotfain, Evgeni, et al.
Publicado: (2016) -
Biomarkers of focal and diffuse traumatic brain injury
por: Vos, Pieter E
Publicado: (2011) -
Monitoring prognosis in severe traumatic brain injury
por: Maas, Andrew IR, et al.
Publicado: (2014)